Adagene Inc. ( ADAG) - Key Metrics
ADAG Revenue per Share metrics
| Date | Revenue per Share | Net Income per Share | Operating Cash Flow | Free Cash Flow per Share |
|---|---|---|---|---|
| 2026Q2 | $0.04 | -$0.36 | -$0.33 | -$0.33 |
| 2025Q4 | $0.20 | -$0.11 | -$0.12 | -$0.12 |
| 2025Q2 | $0 | -$0.36 | -$0.30 | -$0.30 |
| 2024Q4 | $0 | -$0.68 | -$0.63 | -$0.63 |
| 2024Q2 | $0 | -$0.24 | -$0.19 | -$0.19 |
ADAG Payout ratio and Price per Earnings ratio
| Date | Payout ratio | PE ratio |
|---|---|---|
| 2026Q2 | 0% | -2.90 |
| 2025Q4 | 0% | -4.32 |
| 2025Q2 | 0% | -1.34 |
| 2024Q4 | 0% | -0.70 |
| 2024Q2 | 0% | -3.21 |
ADAG
Price: $2.29
52 week price:
Earnings Per Share: -0.37 USD
Exchange: NGM
Sector: Healthcare
Industry: Biotechnology
Country: China
Volume: 47600
Market Capitalization: 106.5 million